Dasatinib-based 2-step induction for adults with Philadelphia chromosome–positive acute lymphoblastic leukemia

The standard treatment for adults with Philadelphia chromosome–positive (Ph(+)) acute lymphoblastic leukemia (ALL) in Japan is imatinib-based chemotherapy followed by allogeneic hematopoietic stem cell transplantation (HSCT). However, ∼40% of patients cannot undergo HSCT in their first complete remi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugiura, Isamu, Doki, Noriko, Hata, Tomoko, Cho, Ryuko, Ito, Toshiro, Suehiro, Youko, Tanaka, Masatsugu, Kako, Shinichi, Matsuda, Mitsuhiro, Yokoyama, Hisayuki, Ishikawa, Yuichi, Taniguchi, Yasuhiro, Hagihara, Maki, Ozawa, Yukiyasu, Ueda, Yasunori, Hirano, Daiki, Sakura, Toru, Tsuji, Masaaki, Kamae, Tsuyoshi, Fujita, Hiroyuki, Hiramoto, Nobuhiro, Onoda, Masahiro, Fujisawa, Shin, Hatta, Yoshihiro, Dobashi, Nobuaki, Nishiwaki, Satoshi, Atsuta, Yoshiko, Kobayashi, Yukio, Hayakawa, Fumihiko, Ohtake, Shigeki, Naoe, Tomoki, Miyazaki, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791587/
https://www.ncbi.nlm.nih.gov/pubmed/34516628
http://dx.doi.org/10.1182/bloodadvances.2021004607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791587/
https://www.ncbi.nlm.nih.gov/pubmed/34516628
http://dx.doi.org/10.1182/bloodadvances.2021004607

Ejemplares similares